Cas no 6683-19-8 (Antioxidant 1010)
Antioxidant 1010 Chemical and Physical Properties
Names and Identifiers
-
- Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
- RALOX 630
- Tetrakis-[methylene(3,5-di-tert.-butyl-4-hydroxy-hydrocinnamate)]methane
- Pentaerythrityl tetrakis-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
- Antioxidant 1010
- Irganox 1010
- Primanox1010
- pentaerythnityl Tetrakis [β- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionate]
- Tetrakis[methylene-β-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate]methane
- BHTOX -1010
- Tetra[methylene-3-(3'.5'-di-t-butyl-4'-hydroxyphenyl)propionate]-methane
- Pentaerythritol-tetra-[β-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate]
- Antioxidant-1010
- Pentaerythritol Tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
- 2,2-Bis(((3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl)oxy)methyl)propane-1,3-diyl bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate)
- tetrakis[methylene-3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)propionate]methane
- Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) Irganox 1010
- Tetrakis[methylene-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]methane
- tetrakis[methyllene-β-(3,5-di-tert-butyl-4-hydroxy phenyl)-propionate]methane
- Tetraalkofen BPE
- Phenosane 23
- Dovernox 10
- Fenozan 22
- Naugard 10
- Fenozan 23
- Sumilizer BP 101
- Irganox 1040
- Irganox 1010FF
- Anox 20AM
- ADK Stab AO 60
- MARK AO 60
- ANOX 20
- Irganox 1010FP
- AO 60
- BP 101
- irganox1010
- RA 1010
- IR 1010
- EI
- Pentaerythritol tetrakis (3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- Rianox 1010
- Pentaerythrityl tetrakis-3-(3',5'-di-t-butyl-4'-hydroxyphenyl)propionate
- Tetrakis-(methylene-(3,5-di-(tert)-butyl-4-hydrocinnamate)) methane
- EC 229-722-6
- Tetrakis(((beta-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyl)oxy)methyl)methane
- Tox21_301970
- Tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxymethyl)methane
- Tetrakis(3-(4-hydroxy-3,5-di-tert-butylphenyl)propionyloxymethyl)methane
- Tetrakis [methylene (3,5-di-t-butyl-4-hydroxyhydrocinnamate)] methane
- Hydrocinnamic acid, 3,5-di-tert-butyl-4-hydroxy-, neopentanetetrayl ester
- Plastic additive 09, European Pharmacopoeia (EP) Reference Standard
- IRGANOX-1010
- PENTAERYTHRITOL 4-HYDROXY-3,5-DI-TERT-BUTYLPHENYLPROPIONATE
- Antioxidant 1010 Solution in Hexane, 1000mug/mL
- Pentaerythritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- STK367172
- 3-([3-(3,5-Ditert-butyl-4-hydroxyphenyl)propanoyl]oxy)-2,2-bis(([3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyl]oxy)methyl)propyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate #
- AC-15274
- Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2,2-bis((3-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxopropoxy)methyl)-1,3-propanediyl ester
- Neopentanetetrayl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate
- CAS-6683-19-8
- SCHEMBL30209
- MFCD00059345
- 3,5-Di-tert-butyl-4-hydroxy-hydrocinnamicacineopentanetetraylester
- Tetrakis(methylene(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)methane
- pentaerythrityl tetrakis (3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- A11596
- DTXSID1027633
- Pentaerythritol, tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- EINECS 229-722-6
- tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl]methane
- 6683-19-8
- PENTAERYTHRITYL TETRAKIS(3,5-DI-TERT- BUTYL-4-HYDROXYHYDROCINNAMATE)
- Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2,2-bis[[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]methyl]-1,3-propanediyl ester
- Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate)
- SY052363
- 2,2-Bis(((3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl)oxy)methyl)propane-1,3-diylbis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate)
- Hydrocinnamic acid, 3,5-di-tert-butyl-4-hydroxy-, tetraester with pentaerythritol
- Plastic additive 2, United States Pharmacopeia (USP) Reference Standard
- AKOS005444166
- DTXCID007633
- 2,2-bis((3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyloxy)methyl)propane-1,3-diyl bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate)
- TINOGARD TTDD
- Pentaerythritol tetrakis[3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)propionate]
- 3-{[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]oxy}-2,2-bis({[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]oxy}methyl)propyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate
- pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate
- Tetrakis[methylene(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)methane]
- CS-W011369
- PLASTIC ADDITIVE 2
- PLASTIC ADDITIVE 2 [USP-RS]
- 2,2-Bis[[[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]oxy]methyl]propane-1,3-diyl Bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate]
- BRN 2035465
- Pentaerithritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- AO3
- PD132638
- PENTAERYTHRITOL TETRAKIS ESTER WITH 3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONIC ACID
- Pentaerithritol tetrakis[3,5-di-tert-butyl-4-hydroxyhydrocinnamate]
- pentaerythrityl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate)
- NS00006684
- HY-W010653
- PENTAERTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE
- Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1,1'-(2,2-bis((3-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)-1-oxopropoxy)methyl)-1,3-propanediyl) ester
- UNII-255PIF62MS
- PLASTIC ADDITIVE 2 (USP-RS)
- Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1,1'-[2,2-bis[[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]methyl]-1,3-propanediyl] ester
- 1ST3113
- PENTAERYTHRITOL 3-(4-HYDROXY-3,5-DI-TERT-BUTYLPHENYL)PROPIONATE (1:4)
- AS-13857
- 1ST3113-1000
- [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate
- P0932
- 255PIF62MS
- TINOGARD TT
- NCGC00255211-01
- Pentaerythritol tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 98%
- Lowinox PP35
- phenosan-23
- CHEMBL3187856
- Q27253913
- W-104737
-
- MDL: MFCD00059345
- Inchi: 1S/C73H108O12/c1-65(2,3)49-33-45(34-50(61(49)78)66(4,5)6)25-29-57(74)82-41-73(42-83-58(75)30-26-46-35-51(67(7,8)9)62(79)52(36-46)68(10,11)12,43-84-59(76)31-27-47-37-53(69(13,14)15)63(80)54(38-47)70(16,17)18)44-85-60(77)32-28-48-39-55(71(19,20)21)64(81)56(40-48)72(22,23)24/h33-40,78-81H,25-32,41-44H2,1-24H3
- InChI Key: BGYHLZZASRKEJE-UHFFFAOYSA-N
- SMILES: O(C(C([H])([H])C([H])([H])C1C([H])=C(C(=C(C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C(C([H])([H])OC(C([H])([H])C([H])([H])C1C([H])=C(C(=C(C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)(C([H])([H])OC(C([H])([H])C([H])([H])C1C([H])=C(C(=C(C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])OC(C([H])([H])C([H])([H])C1C([H])=C(C(=C(C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O
Computed Properties
- Exact Mass: 1176.78000
- Monoisotopic Mass: 1176.784079
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 12
- Heavy Atom Count: 85
- Rotatable Bond Count: 32
- Complexity: 1730
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 5
- XLogP3: 19.4
- Topological Polar Surface Area: 186
Experimental Properties
- Color/Form: White flowable powder. 2. melting point (℃)
- Density: 1.11
- Melting Point: 115-118?°C (dec.) (lit.)
- Boiling Point: 1005.8°C at 760 mmHg
- Flash Point: 247.3±26.4 °C
- Refractive Index: 1.6390 (estimate)
- PSA: 186.12000
- LogP: 15.87920
- Vapor Pressure: 0.0±0.3 mmHg at 25°C
Antioxidant 1010 Security Information
- Signal Word:Warning
- Hazard Statement: H315-H319-H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:-
- Safety Instruction: S22-S24/25
- RTECS:DA8340900
- Storage Condition:Store at room temperature
Antioxidant 1010 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 1544938-200MG |
Antioxidant 1010 |
6683-19-8 | 200mg |
¥3302.56 | 2025-01-16 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR2173-1G |
Antioxidant 1010 |
6683-19-8 | 1g |
¥2260.43 | 2024-12-22 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | P2155009 |
Antioxidant 1010 |
6683-19-8 | European Pharmacopoeia (EP) Reference Standard | ¥2654.27 | 2022-02-23 | ||
| TRC | P227360-5g |
Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate) |
6683-19-8 | 5g |
$ 63.00 | 2023-09-06 | ||
| TRC | P227360-25g |
Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate) |
6683-19-8 | 25g |
$ 80.00 | 2023-09-06 | ||
| TRC | P227360-50g |
Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate) |
6683-19-8 | 50g |
$ 108.00 | 2023-09-06 | ||
| TRC | P227360-100g |
Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate) |
6683-19-8 | 100g |
$176.00 | 2023-05-17 | ||
| TRC | P227360-250g |
Pentaerythritol Tetrakis(3-?(3,?5-?di-?tert-?butyl-?4-?hydroxyphenyl)?propionate) |
6683-19-8 | 250g |
$345.00 | 2023-05-17 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P68390-100g |
2,2-Bis(((3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl)oxy)methyl)propane-1,3-diyl bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate) |
6683-19-8 | 100g |
¥186.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P68390-500g |
2,2-Bis(((3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl)oxy)methyl)propane-1,3-diyl bis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate) |
6683-19-8 | 500g |
¥636.0 | 2021-09-08 |
Antioxidant 1010 Production Method
Production Method 1
Antioxidant 1010 Raw materials
Antioxidant 1010 Preparation Products
- Antioxidant 1010 (6683-19-8)
- Neopentylglycol Bis3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate (36913-60-7)
- 3,5-Bis(1,1-dimethylethyl)-4-hydroxy-3-hydroxy-2,2-bis(hydroxymethyl)propyl Benzenepropanoic Acid Ester (26347-98-8)
- Pentaerythritol Tris Ester With 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic Acid (84633-54-5)
Antioxidant 1010 Suppliers
Antioxidant 1010 Related Literature
-
M. P. Seah,S. J. Spencer,R. Havelund,I. S. Gilmore,A. G. Shard Analyst 2015 140 6508
-
Ana Medi?,Ksenija Stojanovi?,Lidija Izrael-?ivkovi?,Vladimir Be?koski,Branka Lon?arevi?,Sa?a Kazazi?,Ivanka Karad?i? RSC Adv. 2019 9 23696
-
Aurélie Cortéjade,Audrey Buleté,Laura Prouteau,Saber Chatti,Cécile Cren,Emmanuelle Vulliet Anal. Methods 2017 9 3549
-
Dieuwertje Louise Schrijvers,Fabrice Leroux,Vincent Verney,Martin Kumar Patel Green Chem. 2014 16 4969
-
Dieuwertje Louise Schrijvers,Fabrice Leroux,Vincent Verney,Martin Kumar Patel Green Chem. 2014 16 4969
Additional information on Antioxidant 1010
Antioxidant 1010 and CAS No 6683-19-8: A Comprehensive Overview
Antioxidant 1010, identified by the Chemical Abstracts Service registry number CAS No 6683-19-8, is a compound that has garnered significant attention in the field of chemical and biomedical research. This compound, with its unique molecular structure and properties, has been extensively studied for its potential applications in various industries, particularly in the development of novel therapeutic agents and functional materials. The growing interest in Antioxidant 1010 is driven by its remarkable ability to scavenge free radicals and protect biological systems from oxidative stress, a key factor in numerous pathological conditions.
The chemical structure of CAS No 6683-19-8 plays a crucial role in its antioxidant properties. This compound belongs to a class of molecules known for their high efficacy in neutralizing reactive oxygen species (ROS), which are implicated in aging, inflammation, and various chronic diseases. Recent studies have highlighted the compound's ability to modulate cellular signaling pathways, thereby contributing to its therapeutic potential. The molecular interactions between Antioxidant 1010 and biological targets have been a focal point of research, with investigations revealing its role in enhancing mitochondrial function and reducing oxidative damage.
In the realm of biomedical applications, Antioxidant 1010 has shown promise in preclinical trials as a candidate for treating oxidative-related disorders. Its mechanism of action involves the inhibition of enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are pivotal in the production of pro-inflammatory mediators. By targeting these pathways, CAS No 6683-19-8 has demonstrated the ability to reduce inflammation and alleviate symptoms associated with conditions like arthritis and cardiovascular diseases. Furthermore, its stability under various physiological conditions makes it an attractive candidate for formulation into drug delivery systems.
The synthesis and characterization of Antioxidant 1010 have been subjects of extensive research. Advanced synthetic methodologies have been developed to optimize yield and purity, ensuring that the compound meets stringent quality standards for pharmaceutical use. Techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to elucidate its molecular structure and confirm its identity. These analytical methods are crucial for ensuring that the compound's properties align with those predicted from theoretical studies.
The pharmacokinetic profile of CAS No 6683-19-8 is another area of interest. Studies have investigated its absorption, distribution, metabolism, and excretion (ADME) properties to understand how it interacts with biological systems over time. The compound's favorable pharmacokinetic profile suggests that it can be effectively administered orally or topically, depending on the intended application. This versatility makes it suitable for a wide range of therapeutic scenarios, from acute treatments to long-term management strategies.
The environmental impact of Antioxidant 1010 has also been evaluated. Research indicates that this compound is biodegradable and does not accumulate in ecosystems, making it an environmentally friendly option for industrial applications. Its stability under various environmental conditions ensures that it remains effective without posing risks to ecological systems. This characteristic is particularly important for industries that require sustainable practices and compliance with environmental regulations.
The future prospects of CAS No 6683-19-8 are promising, with ongoing research exploring new applications beyond traditional biomedical uses. For instance, its potential as an additive in food products has been examined due to its ability to prevent spoilage caused by oxidative degradation. Additionally, its use in cosmetics has gained traction due to its anti-aging properties, which can help preserve skin health by neutralizing free radicals generated by UV exposure.
In conclusion, Antioxidant 1010, identified by CAS No 6683-19-8, is a multifaceted compound with significant potential in both therapeutic and industrial applications. Its unique chemical properties make it an effective antioxidant agent with broad implications for human health and environmental sustainability. As research continues to uncover new insights into its mechanisms of action and applications, the impact of this compound is expected to grow even further.
6683-19-8 (Antioxidant 1010) Related Products
- 107551-67-7(3-(3-(tert-Butyl)-4-hydroxyphenyl)propanoic acid)
- 115-77-5(Pentaerythritol)
- 2409-55-4(2-Tert-Butyl-4-methylphenol)
- 4075-81-4(Calcium propionate)
- 31570-04-4(Tris(2,4-tert-butylphenyl) Phosphite)
- 128-37-0(Butylated hydroxytoluene)
- 142-77-8(Butyl Oleate)
- 128–37–0(2,6-Di-tert-butyl-4-methylphenol)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)